Want to join the conversation?
$KSS 2Q15 PR: Gross margin for the quarter was $1,662MM compared to $1,654MM in second quarter of 2014. Operating income for the quarter was $424MM compared to $451MM in second quarter of 2014. Company issued $1.1Bil in new notes. In conjunction with refinancing, the Company incurred a loss of approx. $170MM, of which $131MM recognized in 2Q15.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)